# Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

> **NCT00033735** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 158 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** Irofulven

## Key facts

- **NCT ID:** NCT00033735
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2003-06
- **Final completion:** —
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2012-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033735, "Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00033735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*